2m 2m 2m 2m 2m 2m 2m
Haemonetics (HAE)
NYSE
$72.80+$0.27 (+0.37%)
Price as of Jun 23, 2026 4:10 PM EDT- $3.3BMarket Cap
- 0.64%1-Year Change
- Medical DevicesIndustry
Haemonetics (HAE)
$72.80+$0.27 (+0.37%)
Annual
Quarterly
03/28/2026 | 03/29/2025 | 03/30/2024 | 04/01/2023 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.3B -1.97% | 1.4B +3.95% | 1.3B +12.01% | 1.2B +17.67% | |
Cost of Revenue | 546.4M -10.69% | 611.9M -0.91% | 617.5M +11.55% | 553.6M +13.51% | |
Gross Profit | 787.6M +5.16% | 749.0M +8.30% | 691.5M +12.43% | 615.1M +21.68% | |
Sales and Marketing Expense | 442.4M +1.29% | 436.8M +1.16% | 431.8M +14.63% | 376.7M +10.93% | |
Research and Development Expense | -59.8M -4.71% | -62.7M +15.22% | -54.4M +8.59% | -50.1M +7.12% | |
Depreciation and Amortization Expense | 111.7M -3.35% | 115.6M +18.90% | 97.2M +4.19% | 93.3M -4.54% | |
Total Operating Expenses | 630.9M +19.67% | 527.1M +0.09% | 526.7M +14.73% | 459.1M +8.08% | |
Operating Profit | 156.7M -29.34% | 221.8M +34.53% | 164.9M +5.67% | 156.0M +93.23% | |
Interest Income | 2.5M N/A | 0 N/A | 0 N/A | 0 N/A | |
Interest Expense | -1.5M +7.14% | -1.4M +180.00% | -500,000 0.00% | -500,000 -91.38% | |
Interest Income and Expense and Net | 1.0M +171.43% | -1.4M +180.00% | -500,000 0.00% | -500,000 -91.38% | |
Total Nonoperating Income and Expense | -28.7M +194.52% | -9.7M -25.13% | -13.0M -11.02% | -14.6M -14.55% | |
Income before Taxes | 128.0M -39.63% | 212.1M +39.64% | 151.9M +7.40% | 141.4M +122.23% | |
Income Taxes | 30.7M -30.79% | 44.4M +29.40% | 34.3M +31.94% | 26.0M +28.38% | |
Extraordinary Items | 86.5M +3,519.66% | 2.4M -77.05% | 10.4M +1,616.47% | 607,000 -92.37% | |
Net Income | 97.3M -41.97% | 167.7M +42.64% | 117.6M +1.87% | 115.4M +166.05% | |
Net Income from Continuing Operations Applicable to Common | 128.0M -39.63% | 212.1M +39.64% | 151.9M +7.40% | 141.4M +122.23% | |
Basic EPS and Net Income | 2.06 -38.14% | 3.33 +43.53% | 2.32 +2.20% | 2.27 +167.06% | |
Diluted EPS and Net Income | 2.05 -38.07% | 3.31 +44.54% | 2.29 +2.23% | 2.24 +166.67% | |
Basic Weighted Average Shares | 47.2M -6.26% | 50.3M -0.74% | 50.7M -0.15% | 50.8M -0.52% | |
Diluted Weighted Average Shares | 47.4M -6.65% | 50.7M -1.30% | 51.4M -0.04% | 51.4M +0.13% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 245.4M -19.99% | 306.8M +71.57% | 178.8M -37.15% | 284.5M +9.62% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 245.4M -19.99% | 306.8M +71.57% | 178.8M -37.15% | 284.5M +9.62% | |
Total Current Assets | 834.9M -10.71% | 935.0M +21.60% | 768.9M -0.11% | 769.7M +1.81% | |
Accumulated Depreciation | 536.1M -3.09% | 553.1M -14.61% | 647.8M +2.29% | 633.3M +3.71% | |
Property and Plant and Equipment and Net | 305.8M +7.64% | 284.1M -8.77% | 311.4M +0.15% | 310.9M +20.27% | |
Total Long-Term Assets | 141.7M -13.63% | 164.1M +20.32% | 136.4M +27.50% | 107.0M +69.25% | |
Total Assets | 2.4B -2.24% | 2.5B +11.63% | 2.2B +13.48% | 1.9B +4.04% | |
Income Taxes Payable | 38.0M -39.20% | 62.6M -0.11% | 62.6M +73.07% | 36.2M +26.00% | |
Total Short-Term Debt | 5.0M -98.35% | 303.6M +2,867.62% | 10.2M -13.20% | 11.8M -94.50% | |
Total Current Liabilities | 282.6M -51.12% | 578.1M +92.46% | 300.4M +19.29% | 251.8M -43.06% | |
Total Long-Term Debt | 1.2B +32.38% | 921.2M +15.51% | 797.6M +5.76% | 754.1M +34.80% | |
Total Long-Term Liabilities | 59.4M -12.91% | 68.2M -9.12% | 75.0M +0.44% | 74.7M -6.46% | |
Total Liabilities | 282.6M -51.12% | 578.1M +92.46% | 300.4M +19.29% | 251.8M -43.06% | |
Retained Earnings | 279.3M -20.68% | 352.2M -2.30% | 360.5M +42.38% | 253.2M +25.09% | |
Total Stockholders Equity | 796.3M -2.99% | 820.8M -14.49% | 960.0M +17.35% | 818.0M +9.15% | |
Total Shares Outstanding | 45.3M -6.15% | 48.2M -5.06% | 50.8M +0.67% | 50.4M -1.32% | |
Cash Flow | |||||
Cash from Operating Activities | 293.2M +61.35% | 181.7M -0.01% | 181.8M -33.44% | 273.1M +58.51% | |
Capital Expenditures | 32.8M -16.54% | 39.3M -40.75% | 66.3M -39.84% | 110.2M +14.18% | |
Cash from Investing Activities | -179.5M +10.90% | -161.9M -49.78% | -322.4M +124.21% | -143.8M +66.53% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -178.5M -264.00% | 108.8M +185.18% | 38.2M +138.02% | -100.4M +537.27% | |
Financials Ratio | |||||
Gross Margin | 59.04% +7.27% | 55.04% +4.18% | 52.83% +0.37% | 52.63% +3.41% | |
Operating Margin | 11.75% -27.92% | 16.30% +29.41% | 12.60% -5.66% | 13.35% +64.22% | |
Return on Assets | 4.02% -44.37% | 7.22% +26.79% | 5.69% -6.41% | 6.08% +157.99% | |
Return on Equity | 12.03% -36.10% | 18.83% +42.41% | 13.22% -10.19% | 14.73% +151.40% | |
Revenue Growth | -1.97% -149.79% | 3.95% -67.08% | 12.01% -32.00% | 17.67% +25.30% | |
Current Ratio | 2.95 +82.67% | 1.62 -36.82% | 2.56 -16.26% | 3.06 +78.82% | |
Cash Ratio | 0.87 +63.68% | 0.53 -10.85% | 0.60 -47.31% | 1.13 +92.55% | |
Debt-to-Equity Ratio | 1.54 +3.06% | 1.49 +77.31% | 0.84 -10.12% | 0.94 -9.29% | |
Debt-to-Assets Ratio | 0.51 +2.28% | 0.50 +35.82% | 0.37 -7.05% | 0.40 -4.86% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow